Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma

The immune checkpoint inhibitor (ICIs) as Nivolumab and Ipilimumab is a novel class of medication used in the management of several metastatic malignancies. ICIs can cause immune-related adverse events due to autoreactive T cell activation. Cardiovascular complications comprised myocarditis, conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Savarapu, Pramod, Abdelazeem, Basel, Isa, Sakiru, Kesari, Kavitha, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604542/
https://www.ncbi.nlm.nih.gov/pubmed/34804411
http://dx.doi.org/10.1080/20009666.2021.1965708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604542/
https://www.ncbi.nlm.nih.gov/pubmed/34804411
http://dx.doi.org/10.1080/20009666.2021.1965708

Ejemplares similares